GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)

Novus Biologicals, part of Bio-Techne | Catalog # NBP3-51276

Catalog #
Availability
Size / Price
Qty
NBP3-51276-100ul
NBP3-51276-20ul
Print Quote
Bulk Order
100% Guarantee

Key Product Details

Species Reactivity

Human, Mouse, Rat

Applications

Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Knockdown Validated

Label

Unconjugated

Antibody Source

Monoclonal Rabbit IgG Clone # 23GB4380

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

View all GSK-3 alpha/beta Antibodies »

Product Specifications

Immunogen

A synthesized peptide derived from human Phospho-GSK-3 alpha/beta (alpha + beta)(Y216 + Y279) (Uniprot: P49840/P49841)

Modification

p Tyr279

Specificity

This antibody detects endogenous levels of GSK-3 alpha/betaA/GSK-3 alpha/betaB only when phosphorylated at Y216 and Y279

Clonality

Monoclonal

Host

Rabbit

Isotype

IgG

Scientific Data Images for GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)

GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)

Immunocytochemistry/ Immunofluorescence: GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)[NBP3-51276] -

Immunocytochemical staining of C2C12 cells with GSK-3 alpha/beta antibody (1:1,000). Nuclei were stained blue with DAPI; GSK-3 alpha/beta was stained magenta with Alexa Fluor(R) 647. Images were taken using Leica stellaris 5. Protein abundance based on laser Intensity and smart gain: Medium. Scale bar, 20 um.
GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)

Flow Cytometry: GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)[NBP3-51276] -

Flow cytometric analysis of GSK-3 alpha/betaexpression in C2C12 cells using GSK-3 alpha/beta antibody (1:2,000). Green, isotype control; red, Phospho-GSK3 (alpha + beta)(Y216 + Y279).
GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)

Western Blot: GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)[NBP3-51276] -

Western blotting analysis using GSK-3 alpha/beta (alpha + beta)(Y216 + Y279) antibody (1:5,000) and HRP-conjugated goat anti-rabbit secondary antibody (1:20,000) respectively. Image was developed using FeQ(TM) ECL Substrate Kit.

Applications for GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)

Application
Recommended Usage

Flow Cytometry

Optimal dilutions of this antibody should be experimentally determined.

Immunocytochemistry/ Immunofluorescence

Optimal dilutions of this antibody should be experimentally determined.

Knockdown Validated

Optimal dilutions of this antibody should be experimentally determined.

Western Blot

Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS (pH 7.4), 50% glycerol

Preservative

0.02% Sodium Azide

Concentration

Please see the vial label for concentration. If unlisted please contact technical services.

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at -20C. Avoid freeze-thaw cycles.

Background: GSK-3 alpha/beta

Glycogen Synthase Kinase 3beta (GSK-3beta) is a unique serine/threonine kinase that is inactivated by phosphorylation. In response to insulin binding, PKB/AKT phosphorylates GSK-3beta on serine 9, which prevents GSK-3beta from phosphorylating glycogen synthase. Unphosphorylated glycogen synthase is active and able to synthesize glycogen. GSK-3beta is also unique in that it requires a substrate that has been phosphorylated by a distinct kinase before it can phosphorylate the substrate. This phosphate priming mechanism explains why phosphorylation of serine 9 inactivates GSK-3beta. The phosphorylated serine binds to the GSK-3beta priming phosphate position and prevents binding of alternative substrates. In addition to insulin signaling, GSK-3beta participates in the Wnt signaling pathway, where it forms a complex with axin, beta-catenin and adenomatous polyposis coli (APC) protein. In the presence of Wnts, GSK-3beta is unable to phosphorylate beta-catenin, which leads to stabilization of beta-catenin. The Wnt pathway inactivates GSK-3beta via the proteins, Dishevelled and FRAT, which disrupt the interaction of GSK-3beta with axin, beta-catenin, and APC. Clinically, there is considerable interest in GSK-3beta inhibitors because they may mimic the effect of insulin or reduce the hyperphosphorylation of Tau that is observed in Alzheimer's Disease.

Long Name

Glycogen Synthase Kinase 3

Alternate Names

DKFZp686D0638, EC 2.7.11, EC 2.7.11.26, glycogen synthase kinase 3 alpha, glycogen synthase kinase-3 alpha, GSK-3 alpha

Gene Symbol

GSK3A

Additional GSK-3 alpha/beta Products

Product Documents for GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Download SDS

Product Specific Notices for GSK-3 alpha/beta [p Tyr279] Antibody (23GB4380)

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Privacy Policy
Cookie Policy
Site Map
© Copyright 2026 Bio-Techne. All Rights Reserved. All trademarks and registered trademarks are the property of Bio-Techne and its brands unless otherwise specified.